The state government through a notification dated March 17, 2016 denied issuing further licences to manufacture ayurvedic and homeopathic medicines having alcohol content in view of the state government's decision to enforce prohibition from April 1, 2016.
The order was passed by a bench of Chief Justice Iqbal Ahmad Ansari and Justice Samarendra Pratap Singh after hearing two petitions challenging the state government's notification.
Allowing petitions filed by Samrat Chemical Industries and Shree Baidyanath Ayurved Bhawan Pvt Ltd, the bench observed that the state government does not have power to issue such orders denying issuance of licence to the companies for preparation of alternative medicines.
However, the petitioners' counsel Satyabir Bharti along with advocate Alok Chandra contended that the likelihood of misuse could not be the ground to prohibit any firm from carrying out its activities.
The state government does not have power to issue such an order denying licence for manufacturing medicine, rather it is the central government which has the power to do so. And even while doing so, the Centre will have to explain the reasons that it will have harmful effects on the people, Bharti submitted.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
